Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
73.72
-0.23 (-0.31%)
Aug 1, 2025, 4:00 PM - Market closed

Chimerix Revenue

In the fiscal year ending March 31, 2025, Prestige Consumer Healthcare had annual revenue of $1.14B with 1.10% growth. Prestige Consumer Healthcare had revenue of $296.52M in the quarter ending March 31, 2025, with 7.05% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+1.10%
P/S Ratio
3.22
Revenue / Employee
$1,896,270
Employees
600
Market Cap
3.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.14B12.41M1.10%
Mar 31, 20241.13B-2.37M-0.21%
Mar 31, 20231.13B40.91M3.76%
Mar 31, 20221.09B143.45M15.21%
Mar 31, 2021943.37M-19.65M-2.04%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie57.37B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings